93 related articles for article (PubMed ID: 15519490)
1. Topoisomerases mutations and fluoroquinolone resistance in Stenotrophomonas maltophilia.
Trigo Daporta M; Muñoz Bellido JL; García-Rodríguez JA
Int J Antimicrob Agents; 2004 Nov; 24(5):520-1. PubMed ID: 15519490
[No Abstract] [Full Text] [Related]
2. [Investigating the fluoroquinolone molecular resistant mechanism of Stenotrophomonas maltophilia].
Tao CM; Lü XJ; Li P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):266-9. PubMed ID: 16608091
[TBL] [Abstract][Full Text] [Related]
3. [Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area].
Tao CM; Li XC; Lü XJ; Li P; Yu RJ; Gao YY; Chen HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):91-3. PubMed ID: 14981826
[TBL] [Abstract][Full Text] [Related]
4. Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli.
Morgan-Linnell SK; Zechiedrich L
Antimicrob Agents Chemother; 2007 Nov; 51(11):4205-8. PubMed ID: 17682104
[TBL] [Abstract][Full Text] [Related]
5. Emergence of fluoroquinolone-resistant Stenotrophomonas maltophilia in blood isolates causing bacteremia: molecular epidemiology and microbiologic characteristics.
Cha MK; Kang CI; Kim SH; Cho SY; Ha YE; Chung DR; Peck KR; Song JH
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):210-2. PubMed ID: 27117514
[TBL] [Abstract][Full Text] [Related]
6. Emergence of fluoroquinolone resistance and possible mechanisms in clinical isolates of Stenotrophomonas maltophilia from Iran.
Azimi A; Rezaei F; Yaseri M; Jafari S; Rahbar M; Douraghi M
Sci Rep; 2021 May; 11(1):9582. PubMed ID: 33953262
[TBL] [Abstract][Full Text] [Related]
7. Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia.
Shimizu K; Kikuchi K; Sasaki T; Takahashi N; Ohtsuka M; Ono Y; Hiramatsu K
Antimicrob Agents Chemother; 2008 Oct; 52(10):3823-5. PubMed ID: 18644963
[TBL] [Abstract][Full Text] [Related]
8. The antimicrobial susceptibility of Stenotrophomonas maltophilia isolates using three different methods and their genetic relatedness.
Tatman-Otkun M; Gürcan S; Ozer B; Aydoslu B; Bukavaz S
BMC Microbiol; 2005 May; 5():24. PubMed ID: 15882456
[TBL] [Abstract][Full Text] [Related]
9. [Cloning and expression of metallo beta-lactamase encoding gene found in a clinical isolate of Stenotrophomonas maltophilia].
Zhuo C; Qian YS
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1883-7. PubMed ID: 15631799
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of SmeGH contributes to the acquired MDR of Stenotrophomonas maltophilia.
Li LH; Zhang MS; Wu CJ; Lin YT; Yang TC
J Antimicrob Chemother; 2019 Aug; 74(8):2225-2229. PubMed ID: 31086945
[TBL] [Abstract][Full Text] [Related]
11. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units).
Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD; Jonas D
J Hosp Infect; 2006 Nov; 64(3):238-43. PubMed ID: 16979794
[TBL] [Abstract][Full Text] [Related]
12. SmQnrR, a DeoR-type transcriptional regulator, negatively regulates the expression of Smqnr and SmtcrA in Stenotrophomonas maltophilia.
Chang YC; Tsai MJ; Huang YW; Chung TC; Yang TC
J Antimicrob Chemother; 2011 May; 66(5):1024-8. PubMed ID: 21393212
[TBL] [Abstract][Full Text] [Related]
13. Two new variants of and creation of a repository for Stenotrophomonas maltophilia quinolone protection protein (Smqnr) genes.
Wareham DW; Gordon NC; Shimizu K
Int J Antimicrob Agents; 2011 Jan; 37(1):89-90. PubMed ID: 21093222
[No Abstract] [Full Text] [Related]
14. Overexpression of Stenotrophomonas maltophilia major facilitator superfamily protein MfsA increases resistance to fluoroquinolone antibiotics.
Vattanaviboon P; Dulyayangkul P; Mongkolsuk S; Charoenlap N
J Antimicrob Chemother; 2018 May; 73(5):1263-1266. PubMed ID: 29462315
[TBL] [Abstract][Full Text] [Related]
15. SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships.
Gould VC; Avison MB
J Antimicrob Chemother; 2006 Jun; 57(6):1070-6. PubMed ID: 16597633
[TBL] [Abstract][Full Text] [Related]
16. In vitro selection of fluoroquinolone resistance in Brucella melitensis.
Ravanel N; Gestin B; Maurin M
Int J Antimicrob Agents; 2009 Jul; 34(1):76-81. PubMed ID: 19261448
[TBL] [Abstract][Full Text] [Related]
17. Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
Okazaki A; Avison MB
Antimicrob Agents Chemother; 2007 Jan; 51(1):359-60. PubMed ID: 17088477
[TBL] [Abstract][Full Text] [Related]
18. Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital.
Gülmez D; Hasçelik G
Clin Microbiol Infect; 2005 Nov; 11(11):880-6. PubMed ID: 16216102
[TBL] [Abstract][Full Text] [Related]
19. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
[TBL] [Abstract][Full Text] [Related]
20. SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia.
Sánchez MB; Martínez JL
Antimicrob Agents Chemother; 2010 Jan; 54(1):580-1. PubMed ID: 19841154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
